IL6 and Alzheimer disease: Numerous studies have demonstrated the contribution of the C-type lectin receptor signaling pathway to AD pathogenesis, which exacerbates enhanced inflammatory (TNF-α, IL-6, and IL-1β) and Th2 immune responses [88].